A recent analysis from the Global Burden of Disease Study reveals diabetic retinopathy (DR) as a major contributor to global blindness and vision loss, with its prevalence more than tripling from 1990 to 2021. Researchers from The First Hospital of Jilin University found significant increases in DR cases, particularly affecting women aged 65-69, and projected an alarming rise in global prevalence to 1,950,000 by 2035. Key factors driving this trend include population growth and obesity, underscoring the need for improved screening and diabetes management.
The Global Burden of Diabetic Retinopathy
DR prevalence and associated risks of blindness are rising globally, says Global Burden of Disease Study
9/19/2025
2 min read
